Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aideen M Sullivan

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Neuroscience Letters|December 18, 2013
Ventral midbrain neural stem cells have delayed neurogenic potential in vitroShane V Hegarty, Katie Spitere, Aideen M Sullivan, et al.
Parkinsonism & Related Disorders|February 21, 2017
Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysisShane V Hegarty, David J Lee, Gerard W O'Keeffe, et al.
Parkinsonism & Related Disorders|April 20, 2019
Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synucleinSusan R Goulding, Aideen M Sullivan, Gerard W O'Keeffe, et al.
Journal of Cellular and Molecular Medicine|March 23, 2012
Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's diseaseDaniel J Costello, Gerard W O'Keeffe, Fiona M Hurley, et al.
Molecular and Cellular Neurosciences|October 21, 2009
Tumour necrosis factor-alpha impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: Role of Hes1Aoife Keohane, Sinead Ryan, Eimer Maloney, et al.
Neural Regeneration Research|January 31, 2020
The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's diseaseSusan R Goulding, Aideen M Sullivan, Gerard W O'Keeffe, et al.
Behavioural Brain Research|September 27, 2008
Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's diseasePatrick Fitzgerald, Arkady Mandel, Anthony E Bolton, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|October 14, 2025
Pesticide Exposure and Parkinson's Disease: A Qualitative Study of Experiences in IrelandLucy M Collins, Sarah Moore, Emma O'Shea, et al.
Neural Regeneration Research|December 17, 2024
Alpha-synuclein-induced upregulation of SKI family transcriptional corepressor 1: A new player in aging and Parkinson's disease?Lauren Barrett, Rebekah Bevans, Aideen M Sullivan, et al.
Neuroscience Letters|December 31, 2013
6-Hydroxydopamine induces distinct alterations in GDF5 and GDNF mRNA expression in the rat nigrostriatal system in vivoAisling M Gavin, Sinéad Walsh, Sean Wyatt, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Neuroscience Letters|December 18, 2013
Ventral midbrain neural stem cells have delayed neurogenic potential in vitroShane V Hegarty, Katie Spitere, Aideen M Sullivan, et al.
Parkinsonism & Related Disorders|February 21, 2017
Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysisShane V Hegarty, David J Lee, Gerard W O'Keeffe, et al.
Parkinsonism & Related Disorders|April 20, 2019
Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synucleinSusan R Goulding, Aideen M Sullivan, Gerard W O'Keeffe, et al.
Journal of Cellular and Molecular Medicine|March 23, 2012
Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's diseaseDaniel J Costello, Gerard W O'Keeffe, Fiona M Hurley, et al.
Molecular and Cellular Neurosciences|October 21, 2009
Tumour necrosis factor-alpha impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: Role of Hes1Aoife Keohane, Sinead Ryan, Eimer Maloney, et al.
Neural Regeneration Research|January 31, 2020
The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's diseaseSusan R Goulding, Aideen M Sullivan, Gerard W O'Keeffe, et al.
Behavioural Brain Research|September 27, 2008
Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's diseasePatrick Fitzgerald, Arkady Mandel, Anthony E Bolton, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|October 14, 2025
Pesticide Exposure and Parkinson's Disease: A Qualitative Study of Experiences in IrelandLucy M Collins, Sarah Moore, Emma O'Shea, et al.
Neural Regeneration Research|December 17, 2024
Alpha-synuclein-induced upregulation of SKI family transcriptional corepressor 1: A new player in aging and Parkinson's disease?Lauren Barrett, Rebekah Bevans, Aideen M Sullivan, et al.
Neuroscience Letters|December 31, 2013
6-Hydroxydopamine induces distinct alterations in GDF5 and GDNF mRNA expression in the rat nigrostriatal system in vivoAisling M Gavin, Sinéad Walsh, Sean Wyatt, et al.
Pageof 9